1. Activating transcription factor 4 mediates up-regulation of alanine aminotransferase 2 gene expression under metabolic stress
   María C. Salgado et al, 2014, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
2. Hepatic pyruvate and alanine metabolism are critical and complementary for maintenance of antioxidant capacity and resistance to oxidative insult
   Nicole K.H. Yiew et al, 2023, Molecular Metabolism CrossRef
3. New biomarkers for drug‐induced liver injury: are they really better? what do they diagnose?
   John R. Senior, 2014, Liver International CrossRef
4. Intrahepatic and extrahepatic aminotransferase elevation associated with clinical‐therapeutic events in a schizophrenic patient
   Yoshifumi Suzuki et al, 2016, Clinical Case Reports CrossRef
5. Regulation of pyruvate metabolism and human disease
   Lawrence R. Gray et al, 2014, Cellular and Molecular Life Sciences CrossRef
6. Biomarkers in DILI: One More Step Forward
   Mercedes Robles-Díaz et al, 2016, Frontiers in Pharmacology CrossRef
7. Nutraceuticals in hepatic diseases
   Sharon M. Gwaltney-Brant, 2021, Nutraceuticals CrossRef
8. Nutraceuticals in Hepatic Diseases
   Sharon M. Gwaltney-Brant, 2016, Nutraceuticals CrossRef
9. The Evolution of Circulating Biomarkers for Use in Acetaminophen/Paracetamol-Induced Liver Injury in Humans: A Scoping Review
   Mitchell R. McGill et al, 2023, Livers CrossRef
10. Keratin‐18 and microRNA‐122 complement alanine aminotransferase as novel safety biomarkers for drug‐induced liver injury in two human cohorts
    Petra Thulin et al, 2014, Liver International CrossRef
11. A longitudinal assessment of miR-122 and GLDH as biomarkers of drug-induced liver injury in the rat
    Petra Thulin et al, 2017, Biomarkers CrossRef
12. High-throughput screening of the Saccharomyces cerevisiae genome for 2-amino-3-methylimidazo [4,5-f] quinoline resistance identifies colon cancer-associated genes
    Michael Dolan et al, 2023, G3: Genes, Genomes, Genetics CrossRef
13. Elevated levels of circulating CDH5 and FABP1 in association with human drug‐induced liver injury
    Maria Mikus et al, 2017, Liver International CrossRef
14. Liver enzymes, metabolomics and genome-wide association studies: From systems biology to the personalized medicine
    Silvia Sookoian et al, 2015, World Journal of Gastroenterology CrossRef
15. Enzymes involved in l-lactate metabolism in humans
    M. Adeva et al, 2013, Mitochondrion CrossRef
16. Betaine homocysteine methyltransferase (BHMT) as a specific and sensitive blood marker for acute liver injury
    Huailei Ma et al, 2014, Biomarkers CrossRef
17. Specificity of transaminase activities in the prediction of drug-induced hepatotoxicity
    Akio Kobayashi et al, 2020, The Journal of Toxicological Sciences CrossRef
18. Amaryllidaceae, Lycopodiaceae Alkaloids and Coumarins—A Comparative Assessment of Safety and Pharmacological Activity
    Mariola Herbet et al, 2022, Journal of Clinical Medicine CrossRef
19. Circulating mitochondrial biomarkers for drug-induced liver injury
    Qiang Shi et al, 2015, Biomarkers in Medicine CrossRef
20. Validation of a novel point‐of‐care test for alanine aminotransferase measurement: A pilot cohort study
    Jessica Howell et al, 2023, Liver International CrossRef